Recombinant multi-species OTUB1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine OTUB1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The product of this gene is a member of the OTU (ovarian tumor) superfamily of predicted cysteine proteases. The encoded protein is a highly specific ubiquitin iso-peptidase, and cleaves ubiquitin from branched poly-ubiquitin chains but not from ubiquitinated substrates. It interacts with another ubiquitin protease and an E3 ubiquitin ligase that inhibits cytokine gene transcription in the immune system. It is proposed to function in specific ubiquitin-dependent pathways, possibly by providing an editing function for polyubiquitin chain growth. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]
The Alternative Names of target: Deubiquitinating enzyme OTUB1,HSPC263,OTB1,OTU domain-containing ubiquitin aldehyde-binding protein 1,OTU1,OTUB1,Otub1,Otubain-1 (hOTU1),Ubiquitin thioesterase OTUB1,Ubiquitin-specific-processing protease OTUB1

Target products collectionGo to OTUB1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP10198-Ag-1/ GM-Tg-hg-IP10198-Ag-2 Human OTUB1 protein Human
GM-Tg-rg-IP10198-Ag-1/ GM-Tg-rg-IP10198-Ag-2 Rat OTUB1 protein Rat
GM-Tg-mg-IP10198-Ag-1/ GM-Tg-mg-IP10198-Ag-2 Mouse OTUB1 protein Mouse
GM-Tg-cynog-IP10198-Ag-1/ GM-Tg-cynog-IP10198-Ag-2 Cynomolgus/Rhesus macaque OTUB1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP10198-Ag-1/ GM-Tg-felg-IP10198-Ag-2 Feline OTUB1 protein Feline
GM-Tg-cang-IP10198-Ag-1/ GM-Tg-cang-IP10198-Ag-2 Canine OTUB1 protein Canine
GM-Tg-bovg-IP10198-Ag-1/ GM-Tg-bovg-IP10198-Ag-2 Bovine OTUB1 protein Bovine
GM-Tg-equg-IP10198-Ag-1/ GM-Tg-equg-IP10198-Ag-2 Equine OTUB1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP10198-Ag-1/ GM-Tg-hg-IP10198-Ag-2; GM-Tg-rg-IP10198-Ag-1/ GM-Tg-rg-IP10198-Ag-2;
GM-Tg-mg-IP10198-Ag-1/ GM-Tg-mg-IP10198-Ag-2; GM-Tg-cynog-IP10198-Ag-1/ GM-Tg-cynog-IP10198-Ag-2;
GM-Tg-felg-IP10198-Ag-1/ GM-Tg-felg-IP10198-Ag-2; GM-Tg-cang-IP10198-Ag-1/ GM-Tg-cang-IP10198-Ag-2;
GM-Tg-bovg-IP10198-Ag-1/ GM-Tg-bovg-IP10198-Ag-2; GM-Tg-equg-IP10198-Ag-1/ GM-Tg-equg-IP10198-Ag-2
Products Name OTUB1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name OTUB1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine OTUB1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.